Skip to content
← All startups
Cessation Therapeutics logo

Cessation Therapeutics

Series A

Developer of immunotherapy based vaccines to manage addictions. It offer drug conjugate vaccine molecules to overcome addictions such as overcome the opioid, heroin, morphine, fentanyl, alcohol and nicotine addiction use disorders. It contains drug-like “hapten” linked to an immunogenic protein and formulated with immune-stimulating substances directing the immune system to produce antibodies and induce immunity to…

Life Sciences · Neurology · San Jose, United States · EST 2017

About

Developer of immunotherapy based vaccines to manage addictions. It offer drug conjugate vaccine molecules to overcome addictions such as overcome the opioid, heroin, morphine, fentanyl, alcohol and nicotine addiction use disorders. It contains drug-like “hapten” linked to an immunogenic protein and formulated with immune-stimulating substances directing the immune system to produce antibodies and induce immunity to drugs of abuse.

Institutional investors

NIDAHHS

Latest coverage

📰 See all funding news — keep up with the raises that set comps.

Investor directory

🗂️ Full list of active funds — filter by stage, check size, and geography.

Raising like Cessation Therapeutics?

Analyze your pitch deck before your next raise.

Analyze My Deck →